{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:14:46Z","timestamp":1794060886907,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jconrel.2024.04.018","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T21:17:50Z","timestamp":1713043070000},"page":"734-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration"],"prefix":"10.1016","volume":"369","author":[{"given":"M.C.I.","family":"Labonia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Estap\u00e9 Senti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"van der Kraak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.D.","family":"Brans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Dokter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Streef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Deshantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.A.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.G.","family":"Sluijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.04.018_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0010","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0015","series-title":"Chronic Coronary Artery Disease","first-page":"1","article-title":"1 - Epidemiology of chronic coronary artery disease","author":"Wilson","year":"2018"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0020","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc. Disord."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2024.04.018_bb0030","first-page":"156","article-title":"Structural changes in myocardium during acute ischemia","volume":"35","author":"Jennings","year":"1974","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/46.3.338","article-title":"Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology","volume":"46","author":"Ooi","year":"2000","journal-title":"Clin. Chem."},{"issue":"293","key":"10.1016\/j.jconrel.2024.04.018_bb0040","first-page":"e1","volume":"62","year":"2009","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0050","article-title":"Lipid nanoparticles for mRNA delivery","volume":"0123456789","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10557-020-07051-4","article-title":"Modified mRNA as a therapeutic tool for the heart","volume":"34","author":"Kaur","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0060","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.omtm.2020.05.030","article-title":"Synthetic mRNA encoding VEGF-A in patients undergoing coronary artery bypass grafting: design of a Phase 2a clinical trial","volume":"18","author":"Anttila","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0070","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"0","author":"Anttila","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0080","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"First global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0085","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.15585\/mmwr.mm7037e3","article-title":"Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization - five veterans affairs medical centers, United States, February 1-August 6, 2021","volume":"70","author":"Bajema","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0090","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0095","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a Nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0100","doi-asserted-by":"crossref","first-page":"eabf4398","DOI":"10.1126\/sciadv.abf4398","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2019.104837","article-title":"Lipid nanocarriers for microRNA delivery","volume":"226","author":"Scheideler","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2021.11.022","article-title":"Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery","volume":"341","author":"Melamed","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0115","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0120","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","article-title":"Optimizing cardiac delivery of modified mRNA","volume":"25","author":"Sultana","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0125","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2011.3","article-title":"Systemic RNAi-mediated gene silencing in nonhuman primate and rodent myeloid cells","volume":"1","author":"Novobrantseva","year":"2012","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-4157(92)90039-D","article-title":"Phosphatodylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications","volume":"1113","author":"Litzinger","year":"1992","journal-title":"Biochim. Biophys. Acta BBA - Rev. Biomembr."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0140","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.04.018_bb0145","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Aunovska","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vph.2016.05.003","article-title":"Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG","volume":"86","author":"Shah","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4132\/KoreanJPathol.2013.47.4.355","article-title":"ERG immunohistochemistry as an endothelial marker for assessing Lymphovascular invasion","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5414\/NP300817","article-title":"ERG is a novel and reliable marker for endothelial cells in central nervous system tumors","volume":"34","author":"Haber","year":"2015","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yjmcc.2015.02.007","article-title":"Cardiac endothelial cells express Wilms\u2019 tumor-1. Wt1 expression in the developing, adult and infarcted heart","volume":"81","author":"Duim","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0170","doi-asserted-by":"crossref","first-page":"H330","DOI":"10.1152\/ajpheart.00054.2019","article-title":"Platelet-derived growth factor receptor-\u03b1 is essential for cardiac fibroblast survival","volume":"317","author":"Ivey","year":"2019","journal-title":"Am. J. Physiol. - Heart Circ. Physiol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0175","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0180","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0195","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0210","doi-asserted-by":"crossref","first-page":"2000099","DOI":"10.1002\/adtp.202000099","article-title":"Nanoplatforms for mRNA therapeutics","volume":"4","author":"Meng","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202004661","article-title":"Therapeutic delivery of Pip4k2c-modified mRNA attenuates cardiac hypertrophy and fibrosis in the failing heart","volume":"8","author":"Magadum","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0240","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.119.043067","article-title":"Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration","volume":"141","author":"Magadum","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtn.2018.08.021","article-title":"Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration","volume":"13","author":"Magadum","year":"2018","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2022.11.037","article-title":"Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery","volume":"353","author":"Da Silva Sanchez","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0275","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/CIRCULATIONAHA.120.049844","article-title":"Unfolded protein response as a compensatory mechanism and potential therapeutic target in PLN R14del cardiomyopathy","volume":"144","author":"Feyen","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.04.018_bb0280","article-title":"Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant","volume":"59","author":"Lee","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jconrel.2024.04.018_bb0285","article-title":"The isolation and culture of primary Epicardial cells derived from human adult and fetal heart specimens","volume":"57370","author":"Dronkers","year":"2018","journal-title":"J. Vis. Exp. JoVE"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T01:57:22Z","timestamp":1728525442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924002396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":57,"alternative-id":["S0168365924002396"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}